Wolfe Research analyst Alexandria Hammond initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on REGN:
- American upgraded, Regeneron initiated: Wall Street’s top analyst calls
- Regeneron initiated with a Neutral at Citi
- Regeneron announces new, updated data from hematology pipeline at ASH
- Regeneron price target lowered to $1,000 from $1,150 at Oppenheimer
- Regeneron, Sanofi announce EC approval for Dupixent